Radiomics vs. Imaging Biomarkers: Concepts and Clinical Applications

Introduction Radiomics and imaging biomarkers are critical concepts within medical imaging, serving distinct yet complementary roles. This article explores their differences, relationships, and clinical implications, accompanied by case studies demonstrating practical applications. What is Radiomics? Radiomics refers to the extraction of numerous quantitative features from medical images (including MRI, CT, PET/CT and PET/MRI), typically utilizing […]

May 4, 2025 · 4 min read

The Role of Imaging in Oncology Clinical Trials

Clinical drug development is a multi-phase process where imaging is crucial, especially in oncology, to assess the impact of modern therapies beyond traditional tumor size measurements.

June 15, 2025 · 3 min read

Oncohematology and Response Evaluation

Imaging in the Drug Development Process: Clinical drug development involves a multi-phase process, beginning with preclinical studies, advancing through Phase I, II, and III trials, and culminating in regulatory submissions. Imaging plays a pivotal role at each stage, particularly in oncology trials, where traditional tumor size measurement often does not fully capture the effects of […]

May 4, 2025 · 4 min read

This is an article about Real World Evidence and Real-World Validation

April 1, 2025 · 0 min read